Health Science Report
Site Navigation



Research that helps:



Home

  >

Hpv

>

Human Papillomavirus Hpv

>

Human Papillomavirus Vaccine

Human Papillomavirus Vaccine

The human papillomavirus vaccine will prevent the high-risk types of HPV from developing into cancer, the low-risk types cause the penile wart and infections such as vulvar vestibulitis. Another disadvantage of this method is that it only targets the hpv-16 strain and would not eliminate all forms of cancer. The patients were only followed for an average of 2 years, which is not long enough to determine if the protection is lasting. The human papillomavirus vaccine will prevent the high-risk types of HPV from developing into cancer, the low-risk types cause the penile wart and infections such as vulvar vestibulitis.

Just select from the Research Topics on the adjacent gray column for easy viewing of important articles. If this is your first visit, click here for a brief summary of this website.

.

Human Papillomavirus Vaccine

  -  

Penile Wart, Vulvar Vestibulitis

The studies provide hope that vaccination will be available in the nearest future. The remedy targets hpv, a sexually transmitted disease that increases the risk of cervical cancer development. The research aimed at preventing the disease by vaccination showed promising results. The human papillomavirus vaccine will prevent the high-risk types of HPV from developing into cancer, the low-risk types cause the penile wart and infections such as vulvar vestibulitis.

Other Topics: HPV, HPV Treatment, HPV Virus, HPV Picture Symptom Wart, Cause Factor HPV, Human Papillomavirus, Human Papilloma Virus, Cervical Cancer Vaccination, Pap Smear, Male Genital Wart

Dr. Joe Glickman, Jr., M.D.

BBBOnLine Reliability Seal

Copyright © 1996-2009 by Health Science Report™ for the following: